150 related articles for article (PubMed ID: 37286143)
1. SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation.
Gao L; Zhang J; Long Q; Yang Y; Li Y; Li G; Pu P; Tong S; He Y; Li Q; Chen Y; Liu Y; Kong X
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166780. PubMed ID: 37286143
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation.
Zhang WJ; Wu XN; Shi TT; Xu HT; Yi J; Shen HF; Huang MF; Shu XY; Wang FF; Peng BL; Xiao RQ; Gao WW; Ding JC; Liu W
Sci Rep; 2016 Feb; 6():21718. PubMed ID: 26902152
[TBL] [Abstract][Full Text] [Related]
3. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
4. YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer.
Shen B; Li Y; Ye Q; Qin Y
Cancer Gene Ther; 2021 Nov; 28(10-11):1099-1112. PubMed ID: 33323961
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
6. Methylation of KRAS by SETD7 promotes KRAS degradation in non-small cell lung cancer.
Chiang CY; Fan S; Zheng H; Guo W; Zheng Z; Sun Y; Zhong C; Zeng J; Li S; Zhang M; Xiao T; Zheng D
Cell Rep; 2023 Sep; 42(9):113003. PubMed ID: 37682707
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway.
Cao L; Ren Y; Guo X; Wang L; Zhang Q; Li X; Wu X; Meng Z; Xu K
Int J Mol Med; 2020 May; 45(5):1616-1626. PubMed ID: 32323737
[TBL] [Abstract][Full Text] [Related]
8. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.
Yang Z; Ding H; Pan Z; Li H; Ding J; Chen Q
Cancer Biol Ther; 2021 Mar; 22(3):216-224. PubMed ID: 33683171
[TBL] [Abstract][Full Text] [Related]
9. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
Lv J; Wu Q; Li K; Bai K; Yu H; Zhuang J; Sun H; Yang H; Yang X; Lu Q
Int J Biol Sci; 2023; 19(12):3744-3761. PubMed ID: 37564199
[No Abstract] [Full Text] [Related]
10. Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.
Shen BJ; Yang YF; Zhang XX
Thorac Cancer; 2023 Mar; 14(8):746-757. PubMed ID: 36754085
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer.
Byun WS; Kim WK; Yoon JS; Jarhad DB; Jeong LS; Lee SK
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244385
[TBL] [Abstract][Full Text] [Related]
12. YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR.
Zhang C; Chen S; Wang W; Gao Y
Funct Integr Genomics; 2023 Aug; 23(3):269. PubMed ID: 37552345
[TBL] [Abstract][Full Text] [Related]
13. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein.
Shen X; Zhong J; Yu P; Zhao Q; Huang T
Biochem Biophys Res Commun; 2019 Feb; 509(2):448-454. PubMed ID: 30594392
[TBL] [Abstract][Full Text] [Related]
14. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
Wang Z; Petricca J; Liu M; Zhang S; Chen S; Li M; Besschetnova A; Patalano S; Venkataramani K; Siegfried KR; Macoska JA; Han D; Gao S; Vedadi M; Arrowsmith CH; He HH; Cai C
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2220472120. PubMed ID: 37549269
[TBL] [Abstract][Full Text] [Related]
15. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
[TBL] [Abstract][Full Text] [Related]
16. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
17. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis.
Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors.
Su Y; Hopfinger NR; Nguyen TD; Pogash TJ; Santucci-Pereira J; Russo J
J Exp Clin Cancer Res; 2018 Dec; 37(1):314. PubMed ID: 30547810
[TBL] [Abstract][Full Text] [Related]
19. Substrate docking-mediated specific and efficient lysine methylation by the SET domain-containing histone methyltransferase SETD7.
Liu H; Li Z; Yang Q; Liu W; Wan J; Li J; Zhang M
J Biol Chem; 2019 Sep; 294(36):13355-13365. PubMed ID: 31324717
[TBL] [Abstract][Full Text] [Related]
20. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai JT; Chen XH; Leu YL; Weng MS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
